#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Sickle cell anaemia Kidney transplant rejection Oesophageal squamous cell carcinoma stage II Anti-glomerular basement membrane disease Pyoderma gangrenosum Prodromal Alzheimer's disease Vaginal cancer Liposarcoma Cluster headache Epileptic encephalopathy Breast cancer metastatic Adenovirus infection Dent's disease Angiosarcoma metastatic Antiphospholipid antibodies More trials…

    Learn about Rare Diseases

    Primary biliary cholangitis – Diagnostics Pleomorphic leiomyosarcoma – Treatment Hereditary angioedema with C1 esterase inhibitor deficiency – Treatment VEXAS syndrome – Trials in Disease Primary hyperoxaluria – Diagnostics Alveolar rhabdomyosarcoma – Trials in Disease Basal cell naevus syndrome – Diagnostics Hereditary angioedema – Life with Disease Ornithine transcarbamoylase deficiency – Basic Information Leukoencephalopathy – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dexchlorpheniramine Ly3484356 Sildenafil Citrate Ralinepag Elacestrant Dihydrochloride Tianeptine Stro-002 Blu-222 Human Coagulation Factor X Gliquidone Farletuzumab Ecteribulin Vusolimogene Oderparepvec Ceftriaxone Sodium Human Coagulation Factor Ix AMO959 Bjt-778 Midomafetamine Hydrochloride Glimepiride Ivospemin Nitrous Oxide More therapies…

    Learn about Your Condition

    Mucopolysaccharidosis I Foetal growth restriction Respiratory failure Inclusion body myositis Arthroscopy Tubulointerstitial nephritis Stevens-Johnson syndrome Fibrosarcoma metastatic Gout Cervix carcinoma stage II Lymphocytic lymphoma Cardiovascular disorder Breast angiosarcoma Postprandial hypoglycaemia Lysosomal storage disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A study of DT-7012 alone and in combination with pembrolizumab in patients with advanced solid tumors

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm malignant
    France

  • Comparing morphine alone to morphine and lidocaine for pain relief in sickle cell anemia patients with vaso-occlusive crisis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Morphine Hydrochloride
    • Lidocaine Hydrochloride
    Belgium

  • A study testing the safety and effectiveness of inhaled hypochlorous acid in patients with chronic airway infections

    Recruiting

    1 1 1
    Investigated Diseases:
    • Respiratory tract infection
    Investigated Drugs:
    • HYPOCHLOROUS ACID
    Denmark

  • Long-term Safety Study of Tozorakimab for Patients with Chronic Obstructive Pulmonary Disease and History of Exacerbations

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    France

  • Testing a Drug Combination with Fluorouracil, Irinotecan, Oxaliplatin, and Folinic Acid Plus Radiation Therapy for Patients with Advanced Rectal Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rectal cancer
    Investigated Drugs:
    • Fluorouracil
    • Folinic Acid
    • Irinotecan Hydrochloride Trihydrate
    The Netherlands

  • A Study of SPT-300 Compared to Placebo for Adults with Major Depressive Disorder with or without Anxious Distress

    Recruiting

    2 1
    Bulgaria Czechia Germany Hungary Poland Romania +1
Previous Page
1 … 75 76 77 78 79 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!